Infections complicating pancreatitis: diagnosing, treating, preventing

Area of Science:

• Gastroenterology
• Infectious Diseases
• Pharmacology

Background:

• Pancreatic infection is a critical determinant of outcomes in acute necrotizing pancreatitis.
• Bacterial translocation from the colon is the likely route of infection.
• Infection rates range from 40-70% within three weeks, with common pathogens including E. coli and Pseudomonas.

Purpose of the Study:

• To evaluate the efficacy of early broad-spectrum antibiotic therapy in preventing pancreatic infection.
• To identify optimal antibiotic choices based on pharmacodynamic properties and pancreatic penetration.
• To assess the impact of immediate antibiotic initiation on infection rates and surgical management.

Main Methods:

• Review of previous antibiotic efficacy studies focusing on pharmacodynamics.
• Implementation of an immediate 14-day broad-spectrum antibiotic regimen for acute necrotizing pancreatitis.
• Screening for infected necrotizing pancreatitis using fine needle aspiration with Gram staining and culture.

Main Results:

• Antibiotic efficacy varies based on pharmacodynamic properties; imipenem, quinolones, and metronidazole are preferred.
• Aminoglycosides demonstrated poor pancreatic penetration and are not indicated.
• Early antibiotic therapy reduced the infection rate to 33% by the third week.

Conclusions:

• Early and appropriate antibiotic therapy, particularly with imipenem, quinolones, and metronidazole, is beneficial in acute necrotizing pancreatitis.
• This approach can reduce infection rates and optimize conditions for delayed surgical intervention.
• Further randomized controlled trials are needed to establish definitive antibiotic and antifungal regimens.